Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...
Browse 270 market data Tables and 56 Figures spread through 254 Pages and in-depth TOC on "Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type ...
"Our partnership with Elegen allows us to offer customers competitively priced long and complex DNA that they can pair with IDT's extensive portfolio of custom synthetic biology solutions." Matthew ...
Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Butterfly Network, Inc. breached their fiduciary duties to ...
Synthesis of an RBM39 Degrader That Downregulates CEP192 and Induces Disorganized Spindle Structures
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd., Shanghai 201203, China State Key Laboratory of Drug Research, Shanghai ...
Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense oligonucleotide for a rare type of blood cancer. The RNA-targeted ...
This is a framework for RTL synthesis tools. It currently has extensive Verilog-2005 support and provides a basic set of synthesis algorithms for various application domains. Yosys can be adapted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback